Drug Name |
Migalastat
|
||
Synonyms |
DDIG; D-Galactitol, 1,5-dideoxy-1,5-imino; (2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol; 1,5-Dideoxy-1,5-iminogalactitol; 2-(Hydroxymethyl)-3,4,5-piperidinetriol hydrochloride
|
||
Drug Type |
Small molecular drug
|
||
Indications |
Fabry disease [ICD-11: 5C56.01]
|
Approved
|
|
Company |
Amicus Therapeutics
|
||
Summary |
Migalastat is an alpha-galactosidase A chaperone used for the treatment of Fabry disease in patients with an amenable galactosidase alpha gene (GLA) variant.
|
||
Target |
Alpha-galactosidase A (GLA)
Mechanism of Action: Modulator
|
T21678 |
![]() |
Formula |
C6H13NO4
|
Canonical SMILES |
C1C(C(C(C(N1)CO)O)O)O
|
|
InChI |
1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5+,6-/m1/s1
|
|
InChIKey |
LXBIFEVIBLOUGU-DPYQTVNSSA-N
|
|
CAS Number | CAS 108147-54-2 | |
TTD ID | D0MU9L | |
DrugBank ID | DB05018 | |
PubChem Compound ID | 176077 | |
PubChem Substance ID |
796556
,
10258334
,
11114003
,
15066543
,
15321768
,
33499767
,
34884209
,
50069796
,
76308781
,
103329495
,
104049440
,
104425300
,
128553861
,
131271591
,
131481001
,
131481032
,
134348144
,
135154287
,
137263801
,
139879276
,
144203290
,
144221323
,
162774201
,
172232452
,
178483437
,
198184004
,
198975997
,
223733290
,
227686116
,
249807450
,
250135145
|
|
ChEBI ID | CHEBI:135923 | |
ADReCS Drug ID | NA |
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |